v3.26.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 442,209 $ 79,148
Short-term investment securities 72,221 62,822
Accounts receivable, net 392,046 305,628
Inventory 129,029 125,586
Other current assets 51,464 57,580
Total current assets 1,086,969 630,764
Restricted cash 1,352 1,342
Long-term investment securities 61,538 59,136
Right of use assets 6,481 6,278
Deferred tax assets 344,136 348,000
Non-current inventories 26,346 15,689
Other noncurrent assets [1] 2,015 2,044
Total assets 1,528,837 1,063,253
Current liabilities:    
Accounts payable and accrued expenses 148,845 107,508
Other current liabilities [1] 596 2,124
Lease liability – current portion 1,822 1,044
Deferred revenue - current portion [1] 17,190 21,234
Accrued compensation 18,655 21,850
Total current liabilities 187,108 153,760
Deferred revenue, non-current portion 6,863 8,807
Loan payable – non-current 745,140 245,645
Lease liability – non-current 6,595 7,021
Total liabilities 945,706 415,233
Commitments and contingencies
Stockholders’ equity:    
Common stock, $0.001 par value per share (190,000,000 and 190,000,000 shares authorized, 159,965,425 and 158,849,596 shares issued, 153,093,879 and 155,305,953 shares outstanding at March 31, 2026 and December 31, 2025, respectively) 160 159
Additional paid-in capital 1,845,435 1,830,110
Treasury stock, at cost, 6,871,546 and 3,543,643 shares at March 31, 2026 and December 31, 2025, respectively (200,226) (100,234)
Accumulated deficit (1,062,238) (1,082,015)
Total stockholders’ equity 583,131 648,020
Total liabilities and stockholders’ equity $ 1,528,837 $ 1,063,253
[1] Amounts as of December 31, 2023 have been reclassified to conform to current period presentation.